Goldman Sachs’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.62M | Buy |
|
|||||
|
2025
Q1 | $4.27M | Sell |
|
|||||
|
2024
Q4 | $5.74M | Buy |
|
|||||
|
2024
Q3 | $5.01M | Sell |
|
|||||
|
2024
Q2 | $4.65M | Buy |
|
|||||
|
2024
Q1 | $2.45M | Buy |
|
|||||
|
2023
Q4 | $390K | Sell |
|
|||||
|
2023
Q3 | $362K | Sell |
|
|||||
|
2023
Q2 | $1.07M | Buy |
|
|||||
|
2023
Q1 | $952K | Sell |
|
|||||
|
2022
Q4 | $512K | Sell |
|
|||||
|
2022
Q3 | $1.38M | Sell |
|
|||||
|
2022
Q2 | $1.88M | Buy |
|
|||||
|
2022
Q1 | $1.9M | Buy |
|
|||||
|
2021
Q4 | $1.51M | Sell |
|
|||||
|
2021
Q3 | $3.19M | Sell |
|
|||||
|
2021
Q2 | $6.9M | Sell |
|
|||||
|
2021
Q1 | $10.5M | Buy |
|
|||||
|
2020
Q4 | $10.5M | Buy |
|
|||||
|
2020
Q3 | $951K | Sell |
|
|||||
|
2020
Q2 | $1.75M | Buy |
|
|||||
|
2020
Q1 | $421K | Buy |
|
|||||
|
2019
Q4 | $116K | Sell |
|
|||||
|
2019
Q3 | $147K | Buy |
|
|||||
|
2019
Q2 | $150K | Sell |
|
|||||
|
2019
Q1 | $223K | Sell |
|
|||||
|
2018
Q4 | $337K | Buy |
|
|||||
|
2018
Q3 | $333K | Sell |
|
|||||
|
2018
Q2 | $378K | Buy |
|
|||||
|
2018
Q1 | $281K | Buy |
|
|||||
|
2017
Q4 | $156K | Sell |
|
|||||
|
2017
Q3 | $227K | Buy |
|
|||||
|
2017
Q2 | $310K | Buy |
|
|||||
|
2017
Q1 | $297K | Sell |
|
|||||
|
2016
Q4 | $418K | Sell |
|
|||||
|
2016
Q3 | $496K | Buy |
|
|||||
|
2016
Q2 | $237K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $273K | Buy |
|